Meet Pepper, the Humanoid Robot That May Be Coming to a Business Near You
The software developer Luxoft is teaming up with Softbank Robotics America to bring its humanoid robot Pepper to life.
"This is about making robots accessible to the market," said Sam Mantle, the managing director of digital enterprise at Luxoft. He said the technology could be used by a number of different industries, including travel, retail and hospitality.
Pepper, standing about three feet tall, uses data collected by the entire population of Peppers and the cloud, allowing each of the robots to share and growing aggregate intelligence. This enables each Pepper to improve the customer experience, said Mantle.
He added that the technology behind humanoid artificial intelligence is still so new that developers are just beginning to explore how it can help businesses.
"There's always the 'watch out,' there's always the incidences where we can be manipulated, but I think that those sometimes overshadow the real benefits that these types of solutions can bring," he said.
For the full interview, [click here](https://cheddar.com/videos/would-you-like-pepper-with-that).
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
